Table 5 Patient characteristics in the test dataset.
Uplift score ≥ 0.0124 | Uplift score < 0.0124 | P-value | |
|---|---|---|---|
n | 116 | 132 | |
Age | 68.00 [59.75, 73.00] | 66.00 [59.00, 70.00] | 0.393 |
Female sex | 37 (31.9) | 17 (12.9) | < 0.001 |
Body mass index | 24.17 [22.29, 25.76] | 24.45 [22.30, 27.15] | 0.305 |
Family history of atrial fibrillation | 6 (5.2) | 7 (5.3) | > 0.999 |
Long-standing persistent atrial fibrillation | 35 (30.2) | 33 (25.0) | 0.394 |
Hypertension | 75 (64.7) | 78 (59.1) | 0.432 |
Diabetes mellitus | 20 (17.2) | 24 (18.2) | 0.869 |
Dyslipidemia | 48 (41.4) | 58 (43.9) | 0.701 |
Smoking history | 41 (35.3) | 101 (76.5) | < 0.001 |
Heart failure | 24 (20.7) | 17 (12.9) | 0.123 |
Dilated cardiomyopathy | 0 (0.0) | 0 (0.0) | NA |
Hypertrophic cardiomyopathy | 2 (1.7) | 3 (2.3) | > 0.999 |
Sick sinus syndrome | 3 (2.6) | 0 (0.0) | 0.101 |
Stroke or systemic thromboembolism | 9 (7.8) | 7 (5.3) | 0.451 |
Sleep apnea syndrome | 3 (2.6) | 21 (15.9) | < 0.001 |
Thyroid disease | 4 (3.4) | 7 (5.3) | 0.549 |
Chronic obstructive pulmonary disease | 6 (5.2) | 5 (3.8) | 0.759 |
Liver disease | 2 (1.7) | 7 (5.3) | 0.180 |
History of use of anti-arrhythmic drug | 22 19.0) | 34 (25.8) | 0.225 |
Hemoglobin | 14.40 [13.40, 15.10] | 15.20 [14.38, 16.00] | < 0.001 |
Brain type natriuretic peptide | 138.15 [90.62, 178.90] | 152.90 [103.20, 252.50] | 0.017 |
Creatinine | 0.85 [0.75, 1.05] | 0.90 [0.82, 0.98] | 0.199 |
C-reactive protein | 0.10 [0.06, 0.19] | 0.10 [0.06, 0.20] | 0.488 |
Left ventricular ejection fraction | 63.87 [56.63, 71.16] | 63.27 [58.98, 68.69] | 0.950 |
Left atrial diameter | 44.00 [39.00, 46.40] | 42.45 [39.58, 45.00] | 0.063 |
Mitral regurgitation | 5 (4.3) | 1 (0.8) | 0.101 |
Recurrence of atrial fibrillation | 31 (23.5) | 36 (31.0) | 0.199 |
